耐心持有!东方红资产管理江琦:创新药是基本面推动的长周期行情

券商中国
Sep 13

今年以来,创新药板块持续走牛,让医药行业久违地回到了市场“C位”。 在第二批11只浮动费率基金产品中,两只医药行业主题基金备受市场关注。其中一只是来自东方红资产管理的“东方红医疗创新混合基金(QDII)(A类025070、C类025071)”,从业15年的医药老将江琦和基金经理高义拟共同管理该基金。 履历显示,江琦具有15年的证券基金从业经历,为上海交通大学生物工程专业本科、金融学硕士研究生,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10